A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: An NRG oncology RTOG group study

H. Ian Robins, Peixin Zhang, Mark R. Gilbert, Arnab Chakravarti, John F. de Groot, Sean A. Grimm, Fen Wang, Frank S. Lieberman, Andra Krauze, Andy M. Trotti, Nimish Mohile, Andrew Y.J. Kee, Howard Colman, Robert Cavaliere, Santosh Kesari, Steven J. Chmura, Minesh Mehta

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: An NRG oncology RTOG group study'. Together they form a unique fingerprint.

Medicine & Life Sciences